1. Home
  2. IMNM vs AVO Comparison

IMNM vs AVO Comparison

Compare IMNM & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • AVO
  • Stock Information
  • Founded
  • IMNM 2006
  • AVO 1983
  • Country
  • IMNM United States
  • AVO United States
  • Employees
  • IMNM N/A
  • AVO N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • AVO Farming/Seeds/Milling
  • Sector
  • IMNM Health Care
  • AVO Consumer Staples
  • Exchange
  • IMNM Nasdaq
  • AVO Nasdaq
  • Market Cap
  • IMNM 945.8M
  • AVO 893.3M
  • IPO Year
  • IMNM 2020
  • AVO 2020
  • Fundamental
  • Price
  • IMNM $9.69
  • AVO $12.61
  • Analyst Decision
  • IMNM Strong Buy
  • AVO Strong Buy
  • Analyst Count
  • IMNM 8
  • AVO 1
  • Target Price
  • IMNM $24.75
  • AVO $17.00
  • AVG Volume (30 Days)
  • IMNM 756.6K
  • AVO 499.2K
  • Earning Date
  • IMNM 08-06-2025
  • AVO 09-08-2025
  • Dividend Yield
  • IMNM N/A
  • AVO N/A
  • EPS Growth
  • IMNM N/A
  • AVO 66.53
  • EPS
  • IMNM N/A
  • AVO 0.55
  • Revenue
  • IMNM $12,589,000.00
  • AVO $1,426,600,000.00
  • Revenue This Year
  • IMNM N/A
  • AVO $8.85
  • Revenue Next Year
  • IMNM $154.73
  • AVO N/A
  • P/E Ratio
  • IMNM N/A
  • AVO $22.18
  • Revenue Growth
  • IMNM 16.74
  • AVO 25.34
  • 52 Week Low
  • IMNM $5.15
  • AVO $9.56
  • 52 Week High
  • IMNM $16.73
  • AVO $15.25
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 48.73
  • AVO 52.47
  • Support Level
  • IMNM $8.67
  • AVO $11.63
  • Resistance Level
  • IMNM $9.71
  • AVO $13.85
  • Average True Range (ATR)
  • IMNM 0.63
  • AVO 0.46
  • MACD
  • IMNM -0.04
  • AVO -0.04
  • Stochastic Oscillator
  • IMNM 51.64
  • AVO 43.92

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About AVO Mission Produce Inc.

Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.

Share on Social Networks: